KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other financing activities (2016 - 2025)

Biogen has reported Other financing activities over the past 17 years, most recently at -$1.3 million for Q4 2025.

  • Quarterly results put Other financing activities at -$1.3 million for Q4 2025, down 129.55% from a year ago — trailing twelve months through Dec 2025 was $5.0 million (up 327.27% YoY), and the annual figure for FY2025 was $5.0 million, up 327.27%.
  • Other financing activities for Q4 2025 was -$1.3 million at Biogen, down from $6.2 million in the prior quarter.
  • Over the last five years, Other financing activities for BIIB hit a ceiling of $73.7 million in Q4 2021 and a floor of -$94.8 million in Q2 2021.
  • Median Other financing activities over the past 5 years was $1.0 million (2022), compared with a mean of -$661111.1.
  • Biggest five-year swings in Other financing activities: plummeted 5200.0% in 2023 and later surged 3550.0% in 2024.
  • Biogen's Other financing activities stood at $73.7 million in 2021, then plummeted by 99.73% to $200000.0 in 2022, then plummeted by 5200.0% to -$10.2 million in 2023, then surged by 143.14% to $4.4 million in 2024, then crashed by 129.55% to -$1.3 million in 2025.
  • The last three reported values for Other financing activities were -$1.3 million (Q4 2025), $6.2 million (Q3 2025), and -$1.2 million (Q2 2025) per Business Quant data.